Announcements Trials
Browse Landscape

Phase

Phase 1 38Phase 2 17Phase 1/2 7Phase NA 6Phase 3 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 15Brain Neoplasms 15Glioma 9Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Neoplasms by Site 5Neoplasms by Histologic Type 5Hematologic Neoplasms 5Recurrence 4Neuroblastoma 4Astrocytoma 4Spinal Cord Neoplasms 3Lymphoproliferative Disorders 3Lung Neoplasms 3Colorectal Neoplasms 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Medulloblastoma 2Lymphoma 2Laryngeal Neoplasms 2Erdheim-Chester Disease 2Central Nervous System Neoplasms 2cyclopia sequence 1Vitamin D Deficiency 1

Interventions

Vincristine 1Radiotherapy 1Maintenance Chemotherapy 1Lomustine 1Induction Chemotherapy 1Diploidy 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Neuroectodermal Tumors, Primitive × CNS × Clear all
NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Active not recruiting
360 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡